Then, in 2017, Yu et al. [26] also identified the critical role of cyclin-dependent kinase inhibitor 3 (CDKN3) in PCa development via cell cycle and DNA replication signaling. The gene discussed is CDKN3; the disease is posterior cortical atrophy.